HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Education
Visit Zacks'
Education section for investing guides and other free resources to make you a better investor.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


ISIS: Isis Pharmaceuticals Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
ISIS PHARMACEUTICALS INC (NASD)
ISIS 11.23 0.20 (1.81%) Vol.  1,435,173 16.00 CST

Nov 19, 2009 Stock research report available on Isis Pharmaceuticals (NASDAQ:ISIS) from SmarTrend Analytics
Nov 19, 2009 Webcast Alert: Isis Pharmaceuticals Announces Its R&D Webcast Presentation
Nov 19, 2009 BUYINS.NET: Isis Pharmaceuticals (ISIS) Daily Short Sale Trading Volume Through 11-17-09. Over 19.6 Million Shares Shorted in Past 3 Months.
Nov 17, 2009 Isis Pharmaceuticals (ISIS) Is One Of Today's Top Losers On Drug Filing Delay
Nov 17, 2009 Data from Mipomersen Phase 3 Trial in hoFH Patients Presented at AHA
Nov 17, 2009 Altair Therapeutics Gets $17 Million in Financing
Nov 12, 2009 Isis Pharmaceuticals (ISIS) Bearish Technical Alert - Trend Down 15.2%
Nov 12, 2009 Isis Loss Widens
Nov 11, 2009 Webcast Alert: Isis Pharmaceuticals and Genzyme Corporation to Present Mipomersen Phase 3 Data in HoFH During AHA
Nov 10, 2009 Conference Calls Today: 2-2:40 P.M. EDT
Nov 06, 2009 Stock research report available on Isis Pharmaceuticals (NASDAQ:ISIS) from SmarTrend Analytics
Nov 06, 2009 BiomedReports: News and FDA Updates for Isis (Nasdaq:ISIS), VIVUS (Nasdaq:VVUS), MAP (Nasdaq:MAPP)
Nov 05, 2009 Isis Reports Financial Results and Highlights for Third Quarter of 2009
Nov 03, 2009 Isis Pharmaceuticals to Present at the 2009 Canaccord Adams Cardiovascular Conference
Oct 28, 2009 Regulus Announces U.S. Allowance of Fundamental microRNA Therapeutics Patent Application
 
ZACKS COMMENTARY FOR ISIS
Nov 11, 2009 Zacks Blog: Isis Loss Widens
Oct 23, 2009 Zacks Blog: Isis Diabetes Drug Shows Promise
Oct 23, 2009 Zacks Equity Research: Report for ISIS
Jun 24, 2009 Zacks Blog: Zacks Analyst Blog Highlights: Tiffany, Big Lots, Family Dollar, Isis Pharmaceuticals and OncoGenex
Jun 23, 2009 Zacks Blog: Isis Generating Impressive Data
May 07, 2009 Zacks Blog: Isis Our Top Mid-Cap Biotech Pick
Apr 06, 2009 Zacks Blog: ISIS: Big Blockbuster Potential
Mar 17, 2009 Zacks Blog: How to Spend $95 in Biotech
Feb 27, 2009 Zacks Blog: Isis Pharma Maintains a Buy
Jan 05, 2009 Bull of the Day: Isis Pharmaceuticals (ISIS)
Jan 02, 2009 Zacks Blog: Isis with Potential Blockbusters

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research